Profluent
Last verified 2026-05-07. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $44.0Mattributed |
|---|---|
| Latest round | series-a, $35.0M, 2024-03-25attributed |
| Founded | 2022 |
| Headquarters | Berkeley, US |
| Industry | bio |
| Stage | series-a |
| Website | profluent.bio |
Profluent uses AI to design novel proteins for therapeutic and industrial use, including OpenCRISPR, an AI-designed gene editor it released openly. It works with pharma and biotech in genetic medicine and agriculture, partnering with Eli Lilly. Its models build on natural protein scaffolds or author entirely new ones.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2024-03-25 | series-a | $35.0M | undisclosed |
Detected tech stack
Cloudflare, LottieFiles 5.13.0, Google Analytics, Google Font API, Google Hosted Libraries, Google Tag Manager, DoubleClick Floodlight, WordPress, PHP, MySQL, jquery 3.5.1
Provenance
| Fact | Status | Basis |
|---|---|---|
| Series A, $35.0M | attributed | techcrunch named as publisher. No document URL on file. |
| Total raised $44.0M | attributed | techcrunch named as publisher. No document URL on file. |
| Company existence | self-reported | profluent.bio, read 2026-05-07 |
| Description | self-reported | profluent.bio, read 2026-05-07 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.